Woodline Partners’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5M | Buy |
+2,552,536
| New | +$19.5M | 0.1% | 298 |
|
|
2024
Q2 | – | Sell |
-300,170
| Closed | -$1.63M | – | 655 |
|
|
2024
Q1 | $1.63M | Buy |
300,170
+1
| +0% | +$5 | 0.02% | 434 |
|
|
2023
Q4 | $1.63M | Sell |
300,169
-2
| -0% | -$11 | 0.02% | 386 |
|
|
2023
Q3 | $2.64M | Buy |
+300,171
| New | +$2.64M | 0.03% | 373 |
|